Ruta de navegación

Modulos_Cabecera

Aplicaciones anidadas

modulos

The Expert Degree in Immuno-Oncology offered by the School of Medicine of the University of Navarra in collaboration with Bristol Myers Squibb consists of two mentions: 

  • Specialisation in Haematological Neoplasms. The main aim of goal is to provide haematology specialists with specific additional training in new advances in the treatment of haematological neoplasms with monoclonal antibodies, adoptive cell therapy and other advanced therapies.

  • Specialisation in Solid Tumours. The main aim of goal is to provide the specialist in Medical Oncology with specific additional training on new advances in the treatment of solid tumours with monoclonal antibodies, adoptive cell therapy and other advanced therapies.  

The following is a presentation of the programme modules:

inmuno_desplegable_modulos

Title: Fundamentals of Immunology.

Number of European credits (ECTS credit): 1.

Nature (compulsory/optional): Compulsory.

coordinator: Dr. Ignacio Melero.

Classroom part: 24/09/2021 - 25/09/2021. Alumni Building (Madrid).

Online part: classroom Virtual UNAV.

Brief description of the contents:

Dendritic cells.

Antigenic presentation.

T-lymphocyte activation and co-stimulation.

Innate immune response.

Adaptive immune response.

Antibodies and immune response.

Tolerance and immuno-regulation.

Title: Immunology and Cancer: general principles.

Number of European credits (ECTS credit): 1.

Nature (compulsory/optional): Compulsory.

coordinator: Dr. Pablo Sarobe.

Classroom part: 22/10/2021 - 23/10/2021. Alumni Building (Madrid).

Online part: classroom Virtual UNAV.

Brief description of the contents:

The role of the immune system in cancer.

Mechanism of progression: immune evasion.

Mechanism of the anti-tumour immune response.

Tumour antigens and neoantigens.

Cytokines.

Immunomonitoring techniques.

Title: Cancer immunotherapy strategies.

Number of European credits (ECTS credit): 1.

Nature (compulsory/optional): Compulsory.

Coordinator: Dr. Sandra Hervás.

Classroom part: 19/11/2021 - 20/11/2021. Alumni Building (Madrid).

Online part: . classroom Virtual UNAV.

Brief description of the contents:

Immune checkpoint blockade: monoclonal antibodies.

Adoptive cell therapy with tumour infiltrating lymphocytes.

Adoptive cell therapy with transgenic T-cell receptor lymphocytes.

Adoptive cell therapy with chimeric antigen receptor lymphocytes.

Immune mechanisms of radiotherapy potentiation.

Virotherapy.

Title: Precision Medicine in Immuno-Oncology.

Number of European credits (ECTS credit): 1.

Nature (compulsory/optional): Compulsory.

coordinator: Dr. Miguel Sanmamed.

Classroom part: 14/01/2022 - 15/01/2022. Alumni Building (Madrid).

Online part: classroom Virtual UNAV.

Brief description of the contents:

Biomarkers in immunotherapy.

Genomic techniques applied to immunotherapy.

Tumour heterogeneity and immunotherapy.

Advanced research techniques in immunotherapy.

Rational combinations in immunotherapy.

Title: Research in Immuno-Oncology.

Number of European credits (ECTS credit): 1.

Nature (compulsory/optional): Compulsory.

coordinator: Dr. José Luis Pérez Gracia.

Classroom part: 11/03/2022 - 12/03/2022. Alumni Building (Madrid).

Online part: classroom Virtual UNAV.

Brief description of the contents:

design of clinical trials.

Management of immune-related toxicity.

Pharmacology applied to immunotherapy.

Biomarker studies.

Title: Immunology and Medical Oncology I.

Number of European credits (ECTS credit): 1.

Character (compulsory/optional): Optional.

coordinator: Dr. Pedro Berraondo.

Classroom part: 29/04/2022 - 30/04/2022. Alumni Building (Madrid).

Online part: classroom Virtual UNAV.

Brief description of the contents:

Immunotherapy strategies in gynaecological tumours.

Immunotherapy strategies for digestive tumours.

Adoptive cell therapy with tumour infiltrating lymphocytes.

Adoptive cell therapy with NK cells.

Adoptive cell therapy with chimeric antigen receptor lymphocytes for solid tumours.

The laboratory of immunology in cancer immunotherapy.

Monitoring of cell therapy.

Title: Immunology and Haematological Tumours I.

Number of European credits (ECTS credit): 1.

Character (compulsory/optional): Optional.

Coordinator: Dr. Paula Rodríguez Otero.

Classroom part: 29/04/2022 - 30/04/2022. Alumni Building (Madrid).

Online part: . classroom Virtual UNAV.

Brief description of the contents:

Adoptive cell therapy with NK cells.

Adoptive cell therapy with chimeric antigen receptor lymphocytes for solid tumours.

The laboratory of immunology in cancer immunotherapy.

Monitoring of cell therapy.

Adoptive cell therapy with chimeric antigen receptor lymphocytes for haematological malignancies.

Cell therapy for the treatment of viral disease.

Immunotherapy in transplantation.

Experimental immunohaematology.

Title: Immunology and Medical Oncology II.

Number of European credits (ECTS credit): 1.

Character (compulsory/optional): Optional.

coordinator: Dr. Pedro Berraondo.

Classroom part: 27/05/2022 - 28/05/2022. Alumni Building (Madrid).

Online part: classroom Virtual UNAV.

Brief description of the contents:

Immunotherapy strategies in melanoma.

Immunotherapy strategies for thoracic tumours.

Immunotherapy strategies in prostate, bladder and renal cancer.

Immunotherapy strategies in breast cancer.

Immunotherapy strategies in hepatocarcinoma.

Immunotherapy strategies in glioblastoma.

Title: Immunology and Haematological Tumours II.

Number of European credits (ECTS credit): 1.

Character (compulsory/optional): Optional.

Coordinator: Dr. Paula Rodríguez Otero.

Classroom part: 27/05/2022 - 28/05/2022. Alumni Building (Madrid).

Online part: classroom Virtual UNAV.

Brief description of the contents:

Biological basis of immunotherapy strategies for the treatment of haematological tumours and the mechanism of action of immuno-oncology agents.

Clinical trials of adoptive cell therapy with chimeric antigen receptor lymphocytes in haematological malignancies.